Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device
MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ — Sparta Biomedical Inc., a privately held medical technology company, revolutionizing osteoarthritis treatment, is pleased to announce the close of a heavily oversubscribed convertible funding round. The company is thrilled to welcome new medtech... Read More →
Morgantown-based Intermed Labs leverages AI and 3D printing to make prosthetics accessible featuring Fingy3D
MORGANTOWN — Retired coal miner Mark Lance was working with his son at his farm, cutting branches that were overhanging the house. Lance was the ground man holding the rope while his son cut the branches. “A branch came down,... Read More →
Sparta Biomedical’s Breakthrough Device, Ormi, to be Featured at the 17th ICRS World Congress on September 10, 2023
MORRISVILLE, N.C., Sept. 8, 2023 /PRNewswire/ — Sparta Biomedical, a privately held medical device company specializing in partial knee resurfacing, is excited to announce Dr. Adam Yanke’s presentation at the 2023 ICRS World Congress in Barcelona, Spain. Dr. Yanke is... Read More →
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
Thuja Capital and founding investor Sofinnova Partners also joined the round The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based catheter for the treatment of pulmonary hypertension, with initial focus on the... Read More →
VeinWay Closes Oversubscribed SAFE Round and Begins Series A Round
Vascular Surgeons Stephen Black, MD, and Houman Jalaie, MD, PhD join VeinWay’s Scientific Advisory Board. OR YEHUDA, Israel, Sept. 7, 2023 /PRNewswire/ — VeinWay has closed an oversubscribed SAFE round of investment and has opened a series A round. The... Read More →
Velentium Listed on Inc 5000 for Fourth Consecutive Year
Velentium, a professional engineering firm that specializes in the design and manufacturing of therapeutic and diagnostic active medical devices, announces it was once again recognized as one of the fastest-growing private companies in America. Inc. ranked Velentium No. 2725 on... Read More →
Admetsys’ FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
BOSTON, Sept. 6, 2023 /PRNewswire/ — Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device. This designation accelerates the... Read More →
Vitestro starts largest-scale clinical trial globally for its autonomous blood drawing device, with enrolment of first patients in A.D.O.P.T.
UTRECHT, The Netherlands, Sept. 6, 2023 /PRNewswire/ — Vitestro, expert in medical robotics, has launched the A.D.O.P.T. Trial for its autonomous blood drawing device (image). With an anticipated sample size of over 10,000 patients, this is the most significant study... Read More →
Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
Bigfoot developed Bigfoot Unity, a smart insulin management system that features the first and only FDA-cleared connected insulin pen caps that turn data from a continuous glucose monitor (CGM) into clear and reliable insulin dosing recommendations displayed right on the... Read More →
CardieX Sets U.S. IPO at 1.33 Million ADSs Priced at $7.50-$8 Each
Australian medical-device maker CardieX on Wednesday said it plans to sell more than 1.33 million American depositary shares at between $7.50 and $8 apiece in its U.S. initial public offering. Read More